ResMed Inc. (RMD) Financials
RMD Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 6.8 billion | 2.2 billion |
2023-12-31 | 6.9 billion | 2.4 billion |
2023-09-30 | 6.7 billion | 2.5 billion |
2023-06-30 | 6.8 billion | 2.6 billion |
RMD Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | 378.9 million | 20.4 million |
2023-12-31 | 248.3 million | 19.8 million |
2023-09-30 | 245.4 million | 18.5 million |
2023-06-30 | 198.7 million | 19.9 million |
RMD Net Income
Date | Net Income |
---|---|
2024-03-31 | 300.5 million |
2023-12-31 | 208.8 million |
2023-09-30 | 219.4 million |
2023-06-30 | 229.7 million |
RMD Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 237.9 million | - | 160.5 million |
2023-12-31 | 210.2 million | - | 164.7 million |
2023-09-30 | 209.1 million | 1.4 billion | 134.2 million |
2023-06-30 | 227.9 million | 1.4 billion | 138.8 million |
RMD Shares Outstanding
RMD Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 23.1 million | 77.1 million | 229.9 million | - |
2023-12-31 | 24.6 million | 73.9 million | 222.2 million | - |
2023-09-30 | 40.9 million | 75.7 million | 222.9 million | - |
2023-06-30 | 38.7 million | 78.1 million | 240.7 million | - |
RMD Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 1.2 billion | 515.4 million |
2023-12-31 | 1.2 billion | 515.9 million |
2023-09-30 | 963.0 million | 363.0 million |
2023-06-30 | 1.1 billion | 504.7 million |
RMD
List: Contenders
Price: $216.98
Dividend Yield: 0.90%
Forward Dividend Yield: 0.88%
Payout Ratio: 31.74%
Dividend Per Share: 1.92 USD
Earnings Per Share: 6.05 USD
P/E Ratio: 30.52
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 1.2 million
Ebitda: 178.5 millionMarket Capitalization: 31.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 13
DGR3: 4.15%
DGR5: 4.71%
DGR10: 6.53%